Where C6 peptide ELISA (VisE) is reported
Also listed as: VlsE invariant region C6
| Condition | Direction | Compared against | Associated symptoms | Source |
|---|---|---|---|---|
| Lyme Disease | ↑ elevated | Uninfected | High sensitivity in later stages | Bacon et al. 2003 |
Frequently asked questions
In which conditions is C6 peptide ELISA (VisE) altered?
In the OSMF atlas C6 peptide ELISA (VisE) is reported in Lyme Disease. It is elevated in 1 across 1 entries.
Is there a standard clinical test for C6 peptide ELISA (VisE)?
The atlas entries for C6 peptide ELISA (VisE) do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.
Is one abnormal C6 peptide ELISA (VisE) result diagnostic?
No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.
Cite this page
Subscribe on Substack
Last reviewed: 2026-06-29 · Browse: Biomarker Index · All marker pages · Biomarker Atlas
Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.